Oudin, A., Baus, V., Barthelemy, V., Fabian, C., KLEIN, E., Dieterle, M., Wantz, M., Hau, A.-C., DORDING, C., Bernard, A., MICHELUCCI, A., Yabo, Y. A., Kanli, G., Keunen, O., Bjerkvig, R., NICLOU, S. P., & GOLEBIEWSKA, A. (18 June 2021). Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors. STAR Protocols, 2 (2), 100534. doi:10.1016/j.xpro.2021.100534 Peer Reviewed verified by ORBi |
BOUSSAAD, I., CRUCIANI, G., BOLOGNIN, S., ANTONY, P., DORDING, C., KWON, Y.-J., Heuting, P., Fava, E., SCHWAMBORN, J. C., & KRÜGER, R. (2021). Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening. Scientific Reports. doi:10.1038/s41598-021-81129-3 Peer Reviewed verified by ORBi |
Barbuti, P., Santos, B., DORDING, C., CRUCIANI, G., MASSART, F., Hummel, A., & KRÜGER, R. (October 2020). Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA. Stem Cell Research, 48, 101951. doi:10.1016/j.scr.2020.101951 Peer Reviewed verified by ORBi |
BARBUTI, P., ANTONY, P., RODRIGUES SANTOS, B., MASSART, F., CRUCIANI, G., DORDING, C., ARIAS, J., SCHWAMBORN, J. C., & KRÜGER, R. (2020). Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P. Cells, 9 (9). doi:10.3390/cells9092065 Peer Reviewed verified by ORBi |